This indicates that MYCN gene amplification is an early and perhaps initiating event driving the development of a high-risk neuroblastoma subgroup of tumors which is in contrast to most other cancers where gene amplifications are considered to be late events during tumorigenesis (17, 27). The gene discussed is MYCN; the disease is neuroblastoma.